Author Interviews, Cost of Health Care, Pharmacology / 09.12.2023
Pharmacy Forecast: Paradigm Shifts in Breakthrough Therapeutics Will Challenge Existing Payment Models
MedicalResearch.com Interview with:
[caption id="attachment_61125" align="alignleft" width="125"]
Dr. DiPiro[/caption]
Joseph T. DiPiro, Pharm.D
Associate Vice President, Faculty Affairs
Virginia Commonwealth University
Dr. DiPiro is an editor for Pharmacotherapy: A Pathophysiologic Approach
MedicalResearch.com: What is the background for this study?
Response: The ASHP/ASHP Foundation Pharmacy Forecast Report is constructed from a survey of health-system pharmacy leaders who were asked to rate the likelihood of events, scenarios, and trends occurring in the next five years. The purpose is for health-system pharmacists and pharmacy leaders to inform their strategic planning efforts. The Pharmacy Forecast is not intended to predict future events. Rather, the report is intended to be a provocative stimulant for the thinking, discussion, and planning that must take place in every health system. Leaders must be informed of potential developments to help position their organizations to care for patients, enhance population health, and improve medication outcomes.
Dr. DiPiro[/caption]
Joseph T. DiPiro, Pharm.D
Associate Vice President, Faculty Affairs
Virginia Commonwealth University
Dr. DiPiro is an editor for Pharmacotherapy: A Pathophysiologic Approach
MedicalResearch.com: What is the background for this study?
Response: The ASHP/ASHP Foundation Pharmacy Forecast Report is constructed from a survey of health-system pharmacy leaders who were asked to rate the likelihood of events, scenarios, and trends occurring in the next five years. The purpose is for health-system pharmacists and pharmacy leaders to inform their strategic planning efforts. The Pharmacy Forecast is not intended to predict future events. Rather, the report is intended to be a provocative stimulant for the thinking, discussion, and planning that must take place in every health system. Leaders must be informed of potential developments to help position their organizations to care for patients, enhance population health, and improve medication outcomes.
